We are reporting 3 cases of the uterine corpus with collision of @entity4348 ( @entity4348 ) with @entity6019 ( @entity6019 ). The @entity1 ' ages ranged from 36 to 59  years old. The major clinical presentation was abnormal uterine @entity548 . Microscopically, all 3 cases presented with 2 separate components, @entity4348 Grade 1 and @entity6019 (one low grade and two high grades). The @entity4348 component ranged from 10% to 70%, and the @entity6019 component ranged from 30% to 70% of total @entity5 volume. The @entity4348 component was stage 1A in two cases and stage II in one case. The @entity6019 component was stages IA, IIB, and IIIB. Adjuvant hormonal therapy was administrated to one @entity1 while a second @entity1 was treated with chemo/radiation therapy. Two @entity1 were still alive with no evidence of disease at 4  years post-therapy. One @entity1 was lost for follow-up. @entity5 should be distinguished from @entity6962 due to its different treatment modality, outcome and, prognosis.

XXXX associated with @entity6019 : A rare, often unrecognized collision @entity5 .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'Collision tumor'] @entity6019 :: ('MESH:D018203', 'Disease') :: ['endometrial stromal sarcoma', 'ESS'] @entity4348 :: ('MESH:D018269', 'Disease') :: ['EAC', 'endometrioid adenocarcinoma'] @entity6962 :: ('MESH:D002296', 'Disease') :: ['carcinosarcoma']
@entity4348 :: (MESH:D018269,Disease) :: ['Endometrioid adenocarcinoma']
